This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. Materials and Methods Oncology-trained nurses review the charts of all specialty oncology medications that are due to be refilled. HOPA has selected 4.0 Additional information is available here.
Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medicalrecord. Accessed June 2, 2025. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res.
Postmenopausal women with overweight or obesity who were treated simultaneously with tirzepatide and menopause hormone therapy experienced increased weight loss compared to women treated with tirzepatide alone, according to data presented at ENDO 2025, held July 12 to 15 in San Francisco, California. June 30, 2025. References 1.
July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Existing clinical trial models are not considered sustainable. Areas underserved by clinical trials According to the ClinicalTrials.gov, almost 26,000 clinical trials were recorded to be seeking participants across all 50 states in the US in May 2025.
Medicare also doesn’t cover medications for off-label use except when treating cancer. Does Medicaid cover weight loss medication? Medicaid coverage for weight loss medications varies by state. As of 2025, about 13–14 Medicaid state plans cover at least one GLP‑1 receptor agonist.
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook One of the key advantages of blockchain is that it removes the need for patients to provide the same information multiple times. Login Registration is disabled.
For example, researchers have long desired access to a comprehensive database of electronic medicalrecords (EMRs). billion by 2025. Previously, a lack of security, transparency, and standardisation has kept such a system from being fully viable in the market or safe to protect patient privacy. The right tool for a big job.
In response, the Centers for Medicare & Medicaid Services (CMS) introduced Advanced Primary Care Management (APCM) in 2025, a next-generation care management model designed to elevate clinical practice, reduce fragmentation, and reward outcomes over encounters.
The intention is to streamline the process for patients wishing to access their medicalrecords via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted and secure way that preserves privacy. When will it come into force?
A specifically tuned neural network can keep data secure and manage electronic medicalrecords (EMR) to store patients’ sensitive information and treatment records. Apart from gathering and processing supersensitive information, modern AI technologies can manage clinical data storage and organization. Clinical Trials.
Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. And when that data is as sensitive as medicalrecords, the security risks increase exponentially.
This project centres around the use of electronic health records (EHRs) from different European countries to drive research and improve responses to expected and unexpected crises. EHR , or electronic medicalrecords (EMR), have been adopted in multiple countries worldwide over the last few decades.
The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025. It is estimated that this will reach 70% by 2035. Industry interest. Breakthroughs to come.
According to the Deloitte report , the volume of health data rose by 40% between 2010 and 2020 and is predicted to climb even higher by 23% by 2025. It outlines how medical data should be used, protected, and disclosed. Pharma companies deal with enormous amounts of health data.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content